IngredientsUlex europaeus, commonly known as gorse, common gorse, furze, or whin, is a species of flowering plant native to Western Europe. The genus Ulex L. belongs to the family Fabaceae and is well represented in Portugal, where ten species are recognized, some of them endemic; U. europaeus is native mainly to Western Europe. There are three species of Ulex in the UK: the familiar U. europaeus (common gorse), U. gallii (western gorse), and U. minor (dwarf gorse).
The plant's taxonomy places it within the following hierarchy:
The name Ulex is Latin for some unknown ancient plant, while europaeus means "of Europe." The word "gorse" derives from the Anglo-Saxon word "gorst," which is itself a descendant of a German word.
Gorse is an evergreen shrub growing to 4.5 metres (approximately 10 ft) tall. The young stems are green, with shoots and leaves modified into green spines 1–3 centimetres in length; young seedlings produce normal, trifoliate leaves resembling small clover leaves for the first few months. The flowers are 1–2 cm long, with the pea-flower structure typical of the Fabaceae, and are coconut-scented. The fruit is a legume (pod) approximately 2 cm long, dark purplish-brown, partly enclosed by the pale brown remnants of the flower; the pod contains 2–3 small blackish, shiny, hard seeds that are ejected when the pod splits open in hot weather.
The species is hermaphrodite and is pollinated by bees, flies, and beetles; it can fix atmospheric nitrogen, making it an important pioneer plant in nutrient-poor soils. It is suitable for light, medium, and heavy soils, preferring well-drained, mildly acid to neutral conditions, and can grow in nutritionally poor soil.
Gorse is native to the western coast of continental Europe and the British Isles. Outside its natural range, gorse is considered one of the 100 worst invasive species in the world. It was introduced in the early 19th century in Madeira Island (Portugal), where it rapidly became invasive. The invasiveness of the species is closely linked to its ability to sprout and regenerate rapidly, the difficulty of its eradication, high seed production, and fire-resistance.
Various plant parts have been prepared in different ways across historical and contemporary contexts. The primary forms documented in ethnobotanical and phytochemical literature include:
The recorded uses of gorse in folk medicine come predominantly from those parts of the west of the British Isles where it grew; apart from a veterinary use on the Isle of Man, the records come from Ireland without exception. The principal application in Irish folk medicine was for coughs, colds, sore throats, and hoarseness, documented from Down, Londonderry, Donegal, Wicklow, and Waterford — including consumption (tuberculosis) in Limerick. In Londonderry, Wicklow, and Kilkenny it was also used as a tonic, especially for cleansing or "increasing" the blood, while in parts of Ulster, Wicklow, and Wexford it was favoured for heartburn or hiccups.
In Irish folk medicine, it was widely used to treat coughs, colds, sore throats, consumption (tuberculosis), asthma, heartburn, hiccups, jaundice, heart problems, dermatitis, ringworm, swellings, and as a general tonic.
Gorse has never played a major role in mainstream herbal medicine, though its flowers have been used in the treatment of jaundice and as a treatment for scarlet fever in children. The seed is said to be astringent and has been used in the treatment of diarrhoea and stones.
In more recent historical times, gorse was used in medicine for scarlet fever and also jaundice — the latter use was surely the result of the doctrine of signatures (yellow flowers to cure the yellow disease). The flower infusion was an old Wiltshire remedy for dropsy.
In Iberian folk medicine, the flowers have been used in infusions with sugar cane liquor as an antirheumatic, and also for the treatment of liver diseases, diabetes, asthma, and hypertension. Ulex gallii is used in traditional medicine for the same anti-infective, hypotensive, and diuretic purposes as Ulex europaeus, which is the most studied species.
There is a very ancient regard for gorse, particularly the seed, as a means of getting rid of fleas; an Anglo-Saxon version of Dioscorides instructs: "Against fleas, take this wort with its seed, sprinkle it into the house; it killeth the fleas." A 15th-century source similarly advised: "For fleas and lice to slay them — take gorse and seethe it in water, and sprinkle that water about the house, and they will die."
Bruised gorse was used in some areas for feeding to horses and other livestock. For horses, the tops were cut and pounded on a block, and this would be given to the horse, often with a pint of linseed oil. There is limited evidence of its direct human consumption, with the bulk of the documentation largely focused on animal feed; gorse continues to remain a subsistence form of animal feed when high-quality feeds are unavailable.
"Bach Flower Remedies" were invented approximately 80 years ago by the British physician and microbiologist Dr. Edward Bach (1886–1936), who became convinced that most human illnesses are caused by negative states of mind such as fear, jealousy, and despair. Gorse is the Bach Flower Remedy for those who suffer great uncertainty in the process of life, causing them to experience feelings of hopelessness and despair — a state sometimes found in those with long-term illness who have lost all hope of recovery. Dr. Bach classified Gorse as a remedy for uncertainty, not as a remedy for despair alongside Sweet Chestnut.
The screening and quantification of the main phenolic compounds in leaves and flowers of Ulex europaeus was carried out by HPLC-ESI–MSn after ultrasound-assisted extraction with methanol; approximately 98% of compounds identified corresponded to flavonoids, distributed as flavonols, flavones, isoflavones, and flavanones.
The major sub-classes identified are:
Phenolic acids and saponins were also detected in U. europaeus, as minor components.
The plant contains toxic alkaloids and phenolic compounds. While specific alkaloid names from verified sources are limited, quinolizidine alkaloids have been documented in related Ulex species. Compounds such as anagyrine have been identified as extractable chemical constituents of gorse biomass.
Ulex europaeus seeds contain two agglutinins: an L-fucose-binding lectin (UEA I) and UEA II, which is most potently inhibited by N-acetylated chitodextrins and L-Fuc(α1–2)Gal(β1–4)GlcNAc. UEA I is isolated from gorse seeds; it has a molecular weight of 63 kDa, consists of two subunits, and is a glycoprotein with no mitogenic activity that agglutinates type O erythrocytes and, to a lesser degree, A2 erythrocytes. UEA I has a carbohydrate specificity for L-fucose and reacts strongly with alpha(1,2)-linked fucose residues but poorly or not at all with alpha(1,3) or alpha(1,6)-linked fucose.
U. europaeus has demonstrated antioxidant activity due to its high polyphenol content; additionally, it inhibits α-glucosidase and α-amylase activities, effects attributed to its liquiritigenin content. An unsaturated cis fatty acid — alpha-linolenic acid (C18:3 Δ9,12,15) — has been identified as the principal component of the triacylglycerol fraction from the flowers.
The high total polyphenol content, particularly the quercetin glucosides, apigenin derivatives, and liquiritigenin-type flavanones, is the primary basis for documented antioxidant effects. Gorse has been studied for its antioxidant and antifungal properties in the scientific literature. Flavonoids in general scavenge reactive oxygen species (ROS) through electron donation and metal chelation, though specific mechanistic studies on U. europaeus flavonoids in isolation are limited in the peer-reviewed literature reviewed here.
U. europaeus inhibits α-glucosidase and α-amylase activities, effects attributed to its liquiritigenin content. Inhibition of these carbohydrate-hydrolyzing enzymes represents a mechanism relevant to postprandial blood glucose regulation, analogous to pharmaceutical inhibitors such as acarbose. Evidence for this activity in gorse is currently in vitro only.
Two antifungal pterocarpans have been isolated and identified from Ulex europaeus L. Pterocarpans are phytoalexin-type compounds known in legume biochemistry to disrupt fungal cell membranes and interfere with ergosterol biosynthesis, though the precise mechanism for gorse-derived compounds has not been fully elucidated in peer-reviewed sources available at time of writing.
Lectins are highly specific carbohydrate-binding proteins useful in carbohydrate and cell membrane studies, as well as cell agglutination and typing techniques. UEA-I from gorse seeds operates by binding selectively to α-L-fucosyl residues on cell-surface glycoconjugates. It recognizes the Fuc-α-1-2-Gal linkage in fucosylated oligosaccharides that compose portions of various glycoproteins; in particular, the H blood group antigen and carcinoembryonic antigen regularly bind to UEA-I, as does a fucosylated protein expressed by endothelial cells.
In vitro cytotoxicity was evaluated using MTT and LDH assays; D7 and D8 dichloromethane sub-fractions significantly reduced cell viability, triggered early apoptosis in SH-SY5Y and U-87MG cells, and specifically increased ROS levels in U-87MG cells. These effects are preliminary and cell-line specific; no human clinical evidence exists.
Nature of evidence: In vitro only.
Multiple phytochemical studies have confirmed that methanol and aqueous extracts of U. europaeus flower and leaf material exhibit measurable antioxidant activity by standard assays (e.g., DPPH radical scavenging). U. europaeus has demonstrated antioxidant activity due to its high polyphenol content, which includes multiple well-characterized antioxidant flavonoid classes. No controlled human trials assessing antioxidant capacity of gorse preparations were identified in the literature.
Nature of evidence: In vitro only.
Ulex species are a rich source of isoflavonoids — in particular isoflavones and pterocarpans — with relevant antifungal activity. The antifungal activity of isolated isoflavonoid compounds from Ulex species has been tested against Cladosporium cucumerinum by bioautographic TLC assay. Other Ulex species, including U. jussiaei and U. minor, have also shown antifungal properties due to their content of maackiain, 4-methoxymaackiain, 2-methoxymaackiain, isobavachromene, isolupalbigenin, and ulexone A. No human or animal in vivo trials for antifungal applications were identified.
Nature of evidence: In vitro only; no human trials.
U. europaeus stands out for its potential in cancer therapy and diagnosis; a water-soluble extract from U. europaeus seeds has been found to inhibit the growth of various reticuloendothelial tumor cell lines through a non-cytotoxic and reversible mechanism, and some types of myelomas have shown sensitivity to extracts of the same species.
Research on the related species Ulex gallii provides additional relevant data. A study explored the antitumor activity of different sub-fractions of U. gallii methanol extract in glioblastoma (U-87MG and U-373MG) and neuroblastoma (SH-SY5Y) cell lines; cytotoxicity was evaluated using MTT and LDH assays, and D7 and D8 dichloromethane sub-fractions significantly reduced cell viability and triggered early apoptosis. This metabolite-guided study on U. gallii examined A549 (lung cancer) and AGS (stomach cancer) cell lines; three dichloromethane sub-fractions and one methanol sub-fraction showed a time-dependent decrease in cell viability in both A549 and AGS cell lines.
U. europaeus has a high content of bioactive phenolic compounds that may be responsible for its antitumor activity. The isoflavone genistein, found in gorse roots, is itself an established subject of cancer research. All evidence to date is limited to cell-line experiments; no animal model studies or clinical trials on gorse for cancer were identified.
Nature of evidence: In vitro only (one early study).
A search for in vitro antiviral activity of a new isoflavonic glycoside from Ulex europaeus was published in Planta Medica in 1990. This is the primary documented study; the evidence is extremely preliminary and limited to cell-culture conditions. No further clinical or animal research on this specific application was identified.
Nature of evidence: In vitro only; no human trials for gorse specifically.
U. europaeus inhibits α-glucosidase and α-amylase activities, effects attributed to its liquiritigenin content. These enzymes are key targets for the management of type 2 diabetes mellitus; their inhibition slows carbohydrate digestion and attenuates postprandial hyperglycemia. This mechanism parallels that of pharmaceutical inhibitors (e.g., acarbose), but all evidence for gorse remains in vitro.
Nature of evidence: Well established in histochemical research applications; not a dietary supplement use.
This is the area where gorse-derived compounds are most robustly applied in biomedical science, though as laboratory reagents rather than therapeutic agents.
UEA-I agglutinin, a lectin specific for some α-L-fucose-containing glycocompounds, was used in fluorescence microscopy to stain cryostat sections of human tissues; the endothelium of vessels of all sizes was stained ubiquitously in all tissues studied, as confirmed by double staining with antibodies against human clotting factor VIII. UEA I is a highly useful cytochemical marker for the identification of vascular endothelia in paraffin sections of human brain tumors.
UEA I binds to glycoproteins and glycolipids containing α-linked fucose residues, such as ABO blood group glycoconjugates; the lectin is an established marker for human endothelial cells and has been used to differentiate between angiosarcomas and epithelial tumors. This lectin preferentially binds blood group O cells and has been used to determine secretor status.
In oncology research, lectins can recognize cancer cells specifically due to the abnormal glycosylation of molecules on the cancer cell membrane; a UEA-I-based magnetic isolation strategy has been developed to efficiently and specifically capture α-1,2-fucose overexpressing circulating tumor cells (CTCs) from colorectal cancer patients' peripheral blood. Using UEA-I-modified Fe3O4 magnetic beads, up to 94% and 89% of target SW480 colorectal cancer cells were captured from cell-spiked culture medium and whole blood, respectively.
Nature of evidence: No clinical efficacy demonstrated; indistinguishable from placebo in controlled trials.
Gorse is the Bach Flower Remedy for those who suffer great uncertainty, causing feelings of hopelessness and despair — a state sometimes found in those with a long-term illness who have lost all hope of recovery. Despite widespread use, the scientific evidence for Bach Flower Remedies in general is comprehensively negative. A systematic review searched five electronic databases without restrictions on time or language; all randomised clinical trials of flower remedies were included, seven such studies were located, all but one were placebo-controlled, all placebo-controlled trials failed to demonstrate efficacy, and it was concluded that the most reliable clinical trials do not show any differences between flower remedies and placebos. This finding applies to the Bach Flower Remedy system as a whole, including Gorse specifically.
Nature of evidence: Pre-clinical safety modeling; no human trials.
A study aimed to test whether gorse leaf protein concentrate (GLPC) and the protein-depleted fractions obtained from gorse leaves were safe for consumption; GLPC and the protein-depleted fractions were subjected to an in vitro simulated digestion model to understand their digestion as they progress through the digestive tract; uptake was simulated using polarised Caco-2 cells, and cell viability assays were used to test for the absence of toxicity. Establishing food safety in the preliminary laboratory stages of product development involves establishing the absence of potent anti-nutrients; as of August 2023, no reports of toxicity via anti-nutrients in gorse could be found on major literature databases including MEDLINE, Cochrane Central, Scopus, and Google Scholar. This research is at a preliminary, pre-clinical stage.
Based on documented traditional use and current scientific investigation, gorse has been associated with the following body systems and health areas:
The scientific literature on gorse does not establish clinically tested or recommended dosages for human supplementation, as no human clinical trials on herbal gorse preparations for internal use have been published. The following forms and quantities are those noted in relevant sources:
The plant contains toxic alkaloids and phenolic compounds. Only the flowers are edible and should be eaten in moderation; the seeds and pods should never be eaten. The alkaloid content of gorse is analogous to that of related leguminous shrubs (such as Scotch broom, Cytisus scoparius), which contain quinolizidine alkaloids with known cardiovascular and neurotoxic effects at sufficient doses; however, the specific toxicological characterization of gorse alkaloids in peer-reviewed literature is limited.
Establishing food safety involves establishing the absence of potent anti-nutrients; as of August 2023, no reports of toxicity via anti-nutrients in gorse could be found on major literature databases including MEDLINE, Cochrane Central, Scopus, and Google Scholar. This specifically applies to the GLPC preparation and does not negate the alkaloid concern for whole plant or seed consumption.
The long pods and dark seeds are not edible either raw or cooked. Flowers should not be overeaten, as the plant may contain slightly toxic alkaloids; the long pods and dark seeds are not edible.
It is very easy to injure oneself on the spines when harvesting flowers. Physical injury from spines is a consistent foraging hazard noted across all relevant sources.
There is little information about gorse's safety as a plant in food and medicine, and it is seldom used today for either purpose. This is a significant gap: the absence of documented toxicity is not the same as established safety, and the lack of human clinical data means that safe supplemental dosing, contraindications, and drug interactions have not been rigorously characterised in any available source.
No peer-reviewed studies specifically characterizing pharmacokinetic or pharmacodynamic interactions between gorse preparations and pharmaceutical agents were identified in the literature at the time of this writing. Given the isoflavone content (including phytoestrogenic compounds such as genistein), theoretical concerns regarding interactions with hormone-sensitive conditions or hormone therapies may be pertinent, as they are for isoflavone-rich plants generally, but no gorse-specific interaction data were located.
Health conditions that Gorse may help support.
Body systems that Gorse may help support.
Go back